FRANKFURT, March 5 (Reuters) - A German court in Duesseldorf on Wednesday ruled that Pfizer PFE.N and its partner BioNTech 22UAy.DE violated a COVID-19 vaccine patent held by Moderna MRNA.O.
In a statement, the court said that Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that they owe Moderna appropriate compensation, though the ruling can still be appealed to a higher court.
(Reporting by Ludwig Burger, editing by Thomas Escritt)
((ludwig.burger@thomsonreuters.com; +49 30 220133634;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.